Essential Updates: Comp Medical News November
Welcome to this month’s edition of Comp Medical News. Purdue Pharma’s olive branch, decreasing American life expectancy, and antibiotic-resistant infection numbers are your headlines for November 2019.
Welcome to this month’s edition of Comp Medical News. Purdue Pharma’s olive branch, decreasing American life expectancy, and antibiotic-resistant infection numbers are your headlines for November 2019.
Welcome to this month’s edition of Comp Medical News. Marijuana research, drug screening, and compounding rules are your headlines for August 2019.
WCRI released a new study: Interstate Variations in Dispensing of Opioids, 5th Edition, which assesses claims data from 27 states, including Louisiana, from October 2011 to March 2018. The study finds that, in all states studied, fewer injured workers received opioids recently as compared with previous years. Injured workers continue to be treated for pain with NSAIDs, which increased modestly, and other interventions.
Welcome to this month’s edition of Comp Medical News. Traumatic injuries and social acuity, obesity and opioids, and doctor’s notes are your headlines for June 2019.
Welcome to this month’s edition of Comp Medical News. Opioid tapering, depression, and medical marijuana are your headlines for December 2018.
Welcome to this month’s edition of Comp Medical News. Action on medical devices, workplace bullying, and a local pill mill are your headlines for November 2018.
Welcome to this month’s edition of Comp Medical News. Trendy cannabidiol, new medication for low back pain, and opioids are your headlines for October 2018.
Welcome to this month’s Comp Medical News update. Suicide, kratom worries, and a potential non-profit drug company are your headlines for September.
Welcome to this month’s edition of Comp Medical News. Over-the-counter pain medication risks, Purdue pharma’s family ties, and how work can kill you are your headlines for May 2018.
Welcome to this month’s edition of Comp Medical News. Education on medical marijuana, U.S. health spending, and the Justice Department’s role in opioid litigation are you headlines for April 2018.